Skip to main content
Fig. 5 | Journal for ImmunoTherapy of Cancer

Fig. 5

From: Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis

Fig. 5

Kaplan-Meier curves for overall, disease-free and distant metastasis-free survival of patients grouped by their EBV-DNA level and then stratified according to the ICS. Plots show (a) overall survival, (b) disease-free survival and (c) distant metastasis-free survival in the EBV-DNA level > 2000 copy/mL subgroup and (d) overall survival, (e) disease-free survival and (f) distant metastasis-free survival in the EBV-DNA level ≤ 2000 copy/mL subgroup. Abbreviations: ICS, immune checkpoint signature; HR, hazard ratio; and CI, confidence interval

Back to article page